Ingemar Tessin

585 total citations
21 papers, 426 citations indexed

About

Ingemar Tessin is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Pharmacology. According to data from OpenAlex, Ingemar Tessin has authored 21 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 14 papers in Epidemiology and 4 papers in Pharmacology. Recurrent topics in Ingemar Tessin's work include Neonatal and Maternal Infections (17 papers), Pneumonia and Respiratory Infections (12 papers) and Streptococcal Infections and Treatments (9 papers). Ingemar Tessin is often cited by papers focused on Neonatal and Maternal Infections (17 papers), Pneumonia and Respiratory Infections (12 papers) and Streptococcal Infections and Treatments (9 papers). Ingemar Tessin collaborates with scholars based in Sweden, Austria and Israel. Ingemar Tessin's co-authors include Birger Trollfors, Klara Thiringer, Elisabeth Persson, Stellan Håkansson, J. de Louvois, Ron Dagan, Peter Larsson, Margareta Granlund, Pia Axemo and Bo Jacobsson and has published in prestigious journals such as The Journal of Pediatrics, Archives of Disease in Childhood and Acta Paediatrica.

In The Last Decade

Ingemar Tessin

21 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingemar Tessin Sweden 12 311 232 93 69 52 21 426
Daniel K. Benjamin United States 7 334 1.1× 294 1.3× 145 1.6× 106 1.5× 21 0.4× 9 498
Mirasol Apostol United States 6 600 1.9× 453 2.0× 120 1.3× 62 0.9× 27 0.5× 10 705
Phillip S. Wozniak United States 8 297 1.0× 182 0.8× 139 1.5× 82 1.2× 65 1.3× 14 446
P. Joep Dörr Netherlands 12 272 0.9× 195 0.8× 93 1.0× 13 0.2× 36 0.7× 15 448
Håkon Bergseng Norway 11 266 0.9× 173 0.7× 158 1.7× 86 1.2× 18 0.3× 18 430
G Vetrano Italy 9 148 0.5× 220 0.9× 89 1.0× 142 2.1× 29 0.6× 22 481
Paul Hasters Switzerland 6 217 0.7× 228 1.0× 67 0.7× 59 0.9× 8 0.2× 8 339
Anita Niederer-Loher Switzerland 6 218 0.7× 230 1.0× 66 0.7× 61 0.9× 8 0.2× 11 345
Prem Fort United States 6 293 0.9× 201 0.9× 166 1.8× 193 2.8× 22 0.4× 16 519
Alex Donas Switzerland 4 211 0.7× 205 0.9× 65 0.7× 52 0.8× 8 0.2× 7 304

Countries citing papers authored by Ingemar Tessin

Since Specialization
Citations

This map shows the geographic impact of Ingemar Tessin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingemar Tessin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingemar Tessin more than expected).

Fields of papers citing papers by Ingemar Tessin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingemar Tessin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingemar Tessin. The network helps show where Ingemar Tessin may publish in the future.

Co-authorship network of co-authors of Ingemar Tessin

This figure shows the co-authorship network connecting the top 25 collaborators of Ingemar Tessin. A scholar is included among the top collaborators of Ingemar Tessin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingemar Tessin. Ingemar Tessin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adlerberth, Ingegerd, et al.. (2020). Late-onset Neonatal Infections 1997 to 2017 Within a Cohort in Western Sweden—The Last 21 Years of a 43-Year Surveillance. The Pediatric Infectious Disease Journal. 40(4). 359–364. 3 indexed citations
2.
Elfvin, Anders, et al.. (2019). Changes in incidence and etiology of early-onset neonatal infections 1997–2017 – a retrospective cohort study in western Sweden. BMC Pediatrics. 19(1). 490–490. 21 indexed citations
3.
Tessin, Ingemar, et al.. (2015). Very low birthweight infants face an increased risk of bloodstream infections following the removal of umbilical catheters. Acta Paediatrica. 105(4). 391–396. 9 indexed citations
4.
Granlund, Margareta, Pia Axemo, Katarina Bremme, et al.. (2010). Antimicrobial resistance in colonizing group B Streptococci before the implementation of a Swedish intrapartum antibiotic prophylaxis program. European Journal of Clinical Microbiology & Infectious Diseases. 29(10). 1195–1201. 11 indexed citations
5.
Håkansson, Stellan, Pia Axemo, Katarina Bremme, et al.. (2007). Group B streptococcal carriage in Sweden: a national study on risk factors for mother and infant colonisation. Acta Obstetricia Et Gynecologica Scandinavica. 87(1). 50–58. 56 indexed citations
6.
Tessin, Ingemar, et al.. (2003). Invasive group B streptococcal infections in Sweden: incidence, predisposing factors and prognosis. International Journal of Infectious Diseases. 7(2). 113–119. 26 indexed citations
7.
Persson, Elisabeth, et al.. (2002). Septicaemia and meningitis in neonates and during early infancy in the Go¨teborg area of Sweden. Acta Paediatrica. 91(10). 1087–1092. 31 indexed citations
8.
Persson, Elisabeth, et al.. (2002). Septicaemia and meningitis in neonates and during early infancy in the Göteborg area of Sweden. Acta Paediatrica. 91(10). 1087–1092. 6 indexed citations
9.
Sandberg, Kenneth, Anders Fasth, Angelika Berger, et al.. (2000). Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G. The Journal of Pediatrics. 137(5). 623–628. 48 indexed citations
10.
Ladfors, Lars, et al.. (1998). Risk factors for neonatal sepsis in offspring of women with prelabor rupture of the membranes at 34-42 weeks. Journal of Perinatal Medicine. 26(2). 94–101. 28 indexed citations
11.
Berg, Stefan, et al.. (1998). Antibodies to group B streptococci in neonates and infants. European Journal of Pediatrics. 157(3). 221–224. 6 indexed citations
12.
Oldfors, Anders, Tommy Martinsson, Ingemar Tessin, Jan Wahlström, & Shu Wang. (1994). Duchenne muscular dystrophy and spinal muscular atrophy type I segregating in the same family. Clinical Genetics. 45(2). 97–103. 2 indexed citations
13.
Louvois, J. de, et al.. (1992). A comparison of ceftazidime and aminoglycoside based regimens as empirical treatment in 1316 cases of suspected sepsis in the newborn. European Journal of Pediatrics. 151(12). 876–884. 31 indexed citations
14.
Tessin, Ingemar, Birger Trollfors, Klara Thiringer, & Peter Larsson. (1991). Ampicillin–Aminoglycoside Combinations as Initial Treatment for Neonatal Septicaemia or Meningitis:A Retrospective Evaluation of 12 Years' Experience. Acta Paediatrica. 80(10). 911–916. 19 indexed citations
15.
Sjöberg, Inga, et al.. (1990). Incidence of early onset group B streptococcal septicemia in Sweden 1973 to 1985. European Journal of Clinical Microbiology & Infectious Diseases. 9(4). 276–278. 12 indexed citations
16.
Tessin, Ingemar, Birger Trollfors, & Klara Thiringer. (1990). Incidence and Etiology of Neonatal Septicaemia and Meningitis in Western Sweden 1975‐1986. Acta Paediatrica. 79(11). 1023–1030. 67 indexed citations
17.
Tessin, Ingemar, et al.. (1989). Concentrations of ceftazidime, tobramycin and ampicillin in the cerebrospinal fluid of newborn infants. European Journal of Pediatrics. 148(7). 679–681. 13 indexed citations
18.
Tessin, Ingemar, Klara Thiringer, Birger Trollfors, & J.‐E. Brorson. (1988). Comparison of serum concentrations of ceftazidime and tobramycin in newborn infants. European Journal of Pediatrics. 147(4). 405–407. 10 indexed citations
19.
Tessin, Ingemar, et al.. (1988). ENZYMURIA IN NEONATES DURING TREATMENT WITH TOBRAMYCIN OR CEFTAZIDIME. The Pediatric Infectious Disease Journal. 7(2). 142–142. 9 indexed citations
20.
Tessin, Ingemar, et al.. (1987). ENZYMURIA IN NEONATES DURING TREATMENT WITH GENTAMICIN OR TOBRAMYCIN. The Pediatric Infectious Disease Journal. 6(9). 870–870. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel K. Benjamin Breakdown of academic impact, for papers by Mirasol Apostol Breakdown of academic impact, for papers by Phillip S. Wozniak Breakdown of academic impact, for papers by P. Joep Dörr Breakdown of academic impact, for papers by Håkon Bergseng Breakdown of academic impact, for papers by G Vetrano Breakdown of academic impact, for papers by Paul Hasters Breakdown of academic impact, for papers by Anita Niederer-Loher Breakdown of academic impact, for papers by Prem Fort Breakdown of academic impact, for papers by Alex Donas
Rankless by CCL
2026